Madeleine Williams
Stock Analyst at Canaccord Genuity
(0.08)
# 4,369
Out of 4,408 analysts
76
Total ratings
22.6%
Success rate
-22.9%
Average return
Main Sectors:
Stocks Rated by Madeleine Williams
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: CGS Cogstate Limited | Maintained: Buy | $3.15 | $2.76 | +14.13% | 5 | Jun 11, 2026 | |
| ASX: ATH Alterity Therapeutics Limited | Maintained: Buy | $0.01 → $0.95 | $0.53 | +79.25% | 4 | Jun 10, 2026 | |
| ASX: PYC PYC Therapeutics Limited | Maintained: Buy | $2.84 | $1.25 | +126.84% | 3 | Jun 6, 2026 | |
| ASX: CU6 Clarity Pharmaceuticals Ltd | Maintained: Buy | $8.41 | $2.22 | +279.68% | 11 | May 26, 2026 | |
| ASX: SNT Syntara Limited | Maintained: Buy | $0.15 | $0.022 | +581.82% | 8 | May 23, 2026 | |
| ASX: EBR EBR Systems, Inc. | Maintained: Buy | $2.27 | $0.385 | +489.61% | 11 | May 20, 2026 | |
| ASX: NEU Neuren Pharmaceuticals Limited | Maintained: Buy | $24.00 | $12.66 | +89.57% | 5 | May 19, 2026 | |
| ASX: IMR Imricor Medical Systems, Inc. | Rated: Buy | $2.33 → $2.28 | $1.84 | +23.91% | 6 | May 19, 2026 | |
| ASX: PME Pro Medicus Limited | Maintained: Buy | $180.82 → $168.62 | $163.27 | +3.28% | 3 | May 12, 2026 | |
| ASX: M7T Mach7 Technologies Limited | Downgraded: Hold | $0.80 → $0.27 | $0.335 | -19.40% | 2 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.14 | $0.023 | +508.70% | 5 | May 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.23 | $1.94 | +66.49% | 4 | Apr 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.27 → $0.40 | $0.046 | +769.57% | 3 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32.84 → $27.90 | $9.48 | +194.46% | 2 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6.10 | $2.36 | +158.47% | 2 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27.33 → $27.41 | $13.59 | +101.77% | 2 | Oct 15, 2025 |
Cogstate Limited
Jun 11, 2026
Maintained: Buy
Price Target: $3.15
Current: $2.76
Upside: +14.13%
Alterity Therapeutics Limited
Jun 10, 2026
Maintained: Buy
Price Target: $0.01 → $0.95
Current: $0.53
Upside: +79.25%
PYC Therapeutics Limited
Jun 6, 2026
Maintained: Buy
Price Target: $2.84
Current: $1.25
Upside: +126.84%
Clarity Pharmaceuticals Ltd
May 26, 2026
Maintained: Buy
Price Target: $8.41
Current: $2.22
Upside: +279.68%
Syntara Limited
May 23, 2026
Maintained: Buy
Price Target: $0.15
Current: $0.022
Upside: +581.82%
EBR Systems, Inc.
May 20, 2026
Maintained: Buy
Price Target: $2.27
Current: $0.385
Upside: +489.61%
Neuren Pharmaceuticals Limited
May 19, 2026
Maintained: Buy
Price Target: $24.00
Current: $12.66
Upside: +89.57%
Imricor Medical Systems, Inc.
May 19, 2026
Rated: Buy
Price Target: $2.33 → $2.28
Current: $1.84
Upside: +23.91%
Pro Medicus Limited
May 12, 2026
Maintained: Buy
Price Target: $180.82 → $168.62
Current: $163.27
Upside: +3.28%
Mach7 Technologies Limited
May 12, 2026
Downgraded: Hold
Price Target: $0.80 → $0.27
Current: $0.335
Upside: -19.40%
May 3, 2026
Maintained: Buy
Price Target: $0.14
Current: $0.023
Upside: +508.70%
Apr 14, 2026
Maintained: Buy
Price Target: $3.23
Current: $1.94
Upside: +66.49%
Mar 13, 2026
Maintained: Buy
Price Target: $1.27 → $0.40
Current: $0.046
Upside: +769.57%
Mar 2, 2026
Maintained: Buy
Price Target: $32.84 → $27.90
Current: $9.48
Upside: +194.46%
Dec 22, 2025
Maintained: Buy
Price Target: $6.10
Current: $2.36
Upside: +158.47%
Oct 15, 2025
Maintained: Buy
Price Target: $27.33 → $27.41
Current: $13.59
Upside: +101.77%